ImmunityBio (IBRX) Return on Capital Employed Growth (3y) (2018 - 2026)
ImmunityBio (IBRX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
ImmunityBio |
7.55 Bn |
7.17 Bn |
43.97 Mn |
-22,464.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-22,464.00 |
| Dec 31, 2025 |
-30,236.00 |
| Sep 30, 2025 |
6,606.00 |
| Jun 30, 2025 |
-158,429.00 |
| Mar 31, 2025 |
59,831.00 |
| Dec 31, 2024 |
-131,647.00 |
| Sep 30, 2024 |
6,604.00 |
| Jun 30, 2024 |
7,537.00 |
| Mar 31, 2024 |
8,587.00 |
| Dec 31, 2023 |
5,050.00 |
| Sep 30, 2023 |
-3,210.00 |
| Jun 30, 2023 |
20,863.00 |
| Mar 31, 2023 |
24,434.00 |
| Dec 31, 2022 |
29,370.00 |
| Sep 30, 2022 |
-8,603.00 |
| Jun 30, 2022 |
153,302.00 |
| Mar 31, 2022 |
-65,203.00 |
| Dec 31, 2021 |
126,831.00 |
| Sep 30, 2021 |
-11,067.00 |
| Jun 30, 2021 |
-12,219.00 |
